IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
- 1 November 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 289 (5) , G960-G968
- https://doi.org/10.1152/ajpgi.00126.2005
Abstract
Human cytomegalovirus virus (CMV) is a major cause of morbidity and mortality in immunocompromised individuals. Recently, a novel group of cytokines [interleukin (IL)-28A/B and IL-29, also termed interferon (IFN)-λs] has been described. Here, we demonstrate that intestinal epithelial cell (IEC) lines as well as murine and human colonic tissue express the IFN-λ receptor subunits IL-28R and IL-10R2. IL-28A and IL-29 binding to their receptor complex activates ERK-1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase MAPKs and Akt, resulting in increased IL-8 protein expression. IFN-λs also induce phosphorylation of signal transducer and activator of transcription 1 and significantly increase mRNA expression of suppressor of cytokine signaling 3 and the antiviral proteins myxovirus resistance A and 2′,5′-oligoadenylate synthetase. These signals result in an up to 83% reduction of cells positive for human CMV immediate-early protein after human CMV infection. In mice, IL-28A mRNA expression is upregulated after infection with murine CMV in vivo. Both IL-28A and IL-29 significantly decrease cell proliferation but have no effect on Fas-induced apoptosis. In conclusion, IECs express functional receptors for IFN-λs, which mediate antiviral and antiproliferative signals in IECs, suggesting a potential for therapeutic use in certain viral infections and as (antiproliferative) anticancer therapy.Keywords
This publication has 34 references indexed in Scilit:
- SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29Biochemical and Biophysical Research Communications, 2005
- SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2,5-OAS and MxABiochemical and Biophysical Research Communications, 2004
- Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cellsEuropean Journal of Immunology, 2004
- Mutations Conferring Foscarnet Resistance in A Cohort of Patients with Acquired Immunodeficiency Syndrome and Cytomegalovirus RetinitisThe Journal of Infectious Diseases, 2003
- Derangement of apoptosis in cancerThe Lancet, 2001
- Intrahepatic Mrna Expression of Interferon–Inducible Antiviral Genes in Liver Diseases: Dsrna–Dependent Protein Kinase Overexpression and Rnase L Inhibitor Suppression in Chronic Hepatitis CHepatology, 2000
- Efficacy of Low-Dose Oral Use of Type I Interferon in Cytomegalovirus Infections In VivoJournal of Interferon & Cytokine Research, 1999
- Cytomegalovirus Retinitis and Viral ResistanceThe Journal of Infectious Diseases, 1998
- Randomized Phase I Trial of Two Different Combination Foscarnet and Ganciclovir Chronic Maintenance Therapy Regimens for AIDS Patients with Cytomegalovirus Retinitis: AIDS Clinical Trials Group Protocol 151The Journal of Infectious Diseases, 1994
- Cytomegalovirus Disease of the Gastrointestinal Tract in Patients Without AIDSClinical Infectious Diseases, 1993